Controlled release formulation of erythromycin derivatives

Details for Australian Patent Application No. 2004238253 (hide)

Owner Nostrum Pharmaceuticals, Inc.

Inventors Mulye, Nirmal

Agent Davies Collison Cave

Pub. Number AU-B-2004238253

PCT Pub. Number WO2004/100880

Priority 60/468,204 06.05.03 US

Filing date 6 May 2004

Wipo publication date 25 November 2004

Acceptance publication date 27 January 2011

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/100880 Priority application(s): WO2004/100880

27 January 2011 Application Accepted

  Published as AU-B-2004238253

26 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004238257-A method for altering insulin pharmacokinetics

2004238246-Vaccine accelerator factor (VAF) for improvement of vaccinations in poultry